Institution of an Italian Registry and Biobank for Biological Sample Collection

Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Mar 18, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on creating a national registry and biobank for patients with lymphatic malformations (ML), which are rare conditions that can cause growths in the lymphatic system, often appearing at birth or early childhood. The purpose of the registry is to gather important information about these malformations, including how common they are and how they affect different patients. The biobank will collect biological samples from participants to support future research, helping scientists better understand ML and develop new treatments.

Anyone aged 0 to 100 who has been diagnosed with any type of lymphatic malformation can participate in this trial, provided they give their consent. Participants can expect to be part of a comprehensive study that looks at their medical history, treatment outcomes, and how ML impacts their lives. This research aims to improve care for patients with ML and to create better treatment guidelines, ensuring that families receive the best possible support and information.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age 0-100 years
• • 2. Signed informed consent.
• • 3. Individuals with any type of ML (isolated, syndromic, congenital or acquired, with or without molecular confirmation) identified by participating centers
• Exclusion Criteria:
• • Patients whose clinical picture is not compatible with points a) (b) and (c) of the inclusion criteria, as assessed by the Investigator.

Trial Officials